Prosecution Insights
Last updated: October 26, 2026

Bradley James Osinski, USPTO Patent Examiner

Listed by the USPTO as OSINSKI, BRADLEY JAMES

Tech Center 3700 • Art Units: 1742 3763 3767 3783 3797

This examiner grants 78% of resolved cases

Analysis

OSINSKI, BRADLEY JAMES is assigned to Tech Center 3700 and Art Unit 1742. The profile records 1210 resolved cases and an allowance rate of 78.5%. The median time to allowance is 1227 days. Interview lift is 10.9%, showing a positive association between interviews and allowance outcomes in this record.

The company portfolio includes Becton, Dickinson and Company, Sanofi S.A., and Terumo Corporation. The listed firms are Bond, Schoeneck & King, PLLC - SANOFI, BUCHANAN, INGERSOLL & ROONEY PC, and Maschoff Brennan (OC)(BD). Practitioners may use the substantial resolved-case record to frame expectations, while incorporating the reported interview association and median duration into prosecution planning.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

78.5%
Allow Rate
+8.5% vs TC avg
1,256
Total Applications
+10.9%
Interview Lift
1227
Avg Prosecution Days
Based on 1210 resolved cases, 2023–2026

Rejection Statute Breakdown

0.9%
§101 Eligibility
22.2%
§102 Novelty
47.9%
§103 Obviousness
18.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17080578 Rapidly Insertable Central Catheter and Methods Thereof Final Rejection Bard Access Systems, Inc.
18625566 GUIDE TUBE SYSTEMS AND METHODS Non-Final OA Boston Scientific Scimed, Inc.
18742039 CATHETER ASSEMBLY Non-Final OA TERUMO KABUSHIKI KAISHA
18408691 VASCULAR PUNCTURE DEVICE AND VASCULAR PUNCTURE SYSTEM Non-Final OA Terumo Kabushiki Kaisha
17918064 SYSTEMS, DEVICES, AND METHODS FOR DELIVERING A SUBSTANCE WITHIN A TARGET TISSUE Final Rejection The Regents of the University of California
18144940 HEPATIC ARTERIAL INFUSION FOR TREATMENT OF LIVER AILMENTS Non-Final OA Medtronic, Inc.
18669737 DISINFECTION CAP Non-Final OA Becton, Dickinson and Company
18094688 Integrated Catheter System with Near Patient Access Port Non-Final OA Becton, Dickinson and Company
17994974 Male Disinfection Cap Final Rejection Becton, Dickinson and Company
17979165 Disinfecting Device Containing Chlorhexidine-Based Solution Final Rejection Becton, Dickinson and Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Bradley James Osinski's allowance rate?

78.5% of resolved applications examined by Bradley James Osinski were allowed (1,210 resolved cases), compared with 58.3% across Art Unit 1742 over the last five years.

Does an interview help with examiner Bradley James Osinski?

This examiner's interview lift is +10.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Bradley James Osinski take to allow a patent?

Applications allowed by Bradley James Osinski took 1,227 days on average from filing to allowance.

Which art unit does examiner Bradley James Osinski work in?

Bradley James Osinski examines applications in Art Unit 1742 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month